A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality. - Sorbonne Université
Journal Articles Emerging microbes & infections Year : 2021

A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality.

Serge Camelo
Mathilde Latil
  • Function : Author
Sam Agus
  • Function : Author
Waly Dioh
  • Function : Author
Stanislas Veillet
  • Function : Author
René Lafont
Pierre J Dilda
  • Function : Author

Abstract

Since December 2019, coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has changed our lives. Elderly, and those with comorbidities represent the vast majority of patients hospitalized with severe COVID-19 symptoms, including acute respiratory disease syndrome, and cardiac dysfunction. Despite a huge effort of the scientific community, improved treatment modalities limiting the severity and mortality of hospitalized COVID-19 patients, are still required. Here, we compare the effectiveness of virus- and patients-centred strategies to reduce COVID-19 mortality. We also discuss the therapeutic options that might further reduce death rates associated with the disease in the future. Unexpectedly, extensive review of the literature suggests that SARS-CoV-2 viral load seems to be associated neither with the severity of symptoms nor with mortality of hospitalized patients with COVID-19. This may explain why, so far, virus-centred strategies using antivirals aiming to inhibit the viral replicative machinery, have failed to reduce COVID-19 mortality in patients with respiratory failure. By contrast, anti-inflammatory treatments without antiviral capacities but centred on patients, such as dexamethasone or Tocilizumab®, reduce COVID-19 mortality. Finally, since the spike protein of SARS-CoV-2 binds to Angiotensin Converting Enzyme 2 (ACE2) and inhibits its function, we explore the different treatment options focussing on rebalancing the Renin-Angiotensin System (RAS). This new therapeutic strategy could hopefully further reduce the severity of respiratory failure and limit COVID-19 mortality in elderly patients.
Fichier principal
Vignette du fichier
A comparison between virus versus patients centred therapeutic attempts to reduce COVID 19 mortality.pdf (997.06 Ko) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03440856 , version 1 (22-11-2021)

Identifiers

Cite

Serge Camelo, Mathilde Latil, Sam Agus, Waly Dioh, Stanislas Veillet, et al.. A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality.. Emerging microbes & infections, 2021, pp.1-20. ⟨10.1080/22221751.2021.2006579⟩. ⟨hal-03440856⟩
22 View
154 Download

Altmetric

Share

More